Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [2389]

Dose escalation of RG6344 demonstrates safety and promising activity in BRAF...

Dr Maria Vieito - Vall d'Hebron Institute of Oncology, Barcelona, Spain

Dose escalation of RG6344 demonstrates safety and promising activity in BRAF V600E solid tumours ( Dr Maria Vieito - Vall d'Hebron Institute of Oncology, Barcelona, Spain )

Treatment management of favourable risk and very favourable risk patients

Dr Guillermo de Velasco and Dr Marco Maruzzo

Treatment management of favourable risk and very favourable risk patients ( Dr Guillermo de Velasco and Dr Marco Maruzzo )

Phase I/II trial shows promising activity of invikafusp alfa in PD-1–resistant...

Dr Elena Élez - Vall d'Hebron Institute of Oncology, Barcelona, Spain

Phase I/II trial shows promising activity of invikafusp alfa in PD-1–resistant GI cancers ( Dr Elena Élez - Vall d'Hebron Institute of Oncology, Barcelona, Spain )

Nivolumab plus ipilimumab improves survival results in MSI-H/dMMR metastatic...

Dr Elena Élez - Vall d'Hebron Institute of Oncology, Barcelona, Spain

Nivolumab plus ipilimumab improves survival results in MSI-H/dMMR metastatic colorectal cancer ( Dr Elena Élez - Vall d'Hebron Institute of Oncology, Barcelona, Spain )

Key insights from head and neck research at ASCO 2025

Dr Barbara Burtness - Yale School of Medicine, New Haven, USA

Key insights from head and neck research at ASCO 2025 ( Dr Barbara Burtness - Yale School of Medicine, New Haven, USA )

Florida Atlantic University and Memorial Cancer Institute collaboration

Dr Gregg B. Fields - Florida Atlantic University, Florida, USA

Florida Atlantic University and Memorial Cancer Institute collaboration ( Dr Gregg B. Fields - Florida Atlantic University, Florida, USA )

Clinical advances in cancer molecular testing: the patient's perspective

Paul Hakimata - Memorial Healthcare System, Miami, USA

Clinical advances in cancer molecular testing: the patient's perspective ( Paul Hakimata - Memorial Healthcare System, Miami, USA )

Updates on gastrointestinal cancer treatments ASCO 2025

Dr Mike Cusnir - Mount Sinai Medical Center, Miami, USA

Updates on gastrointestinal cancer treatments ASCO 2025 ( Dr Mike Cusnir - Mount Sinai Medical Center, Miami, USA )

Advancements in gastrointestinal cancer treatments at ASCO 2025

Dr Jesus Fabregas - Memorial Cancer Institute, Miami, USA

Advancements in gastrointestinal cancer treatments at ASCO 2025 ( Dr Jesus Fabregas - Memorial Cancer Institute, Miami, USA )

Understanding genetic aberrations in lung cancer treatment: NTRK, RET, NRG

Dr Luis E. Raez - Memorial Cancer Institute, Miami, USA

Understanding genetic aberrations in lung cancer treatment: NTRK, RET, NRG ( Dr Luis E. Raez - Memorial Cancer Institute, Miami, USA )

Future of chemotherapy and targeted therapies

Dr Natasha Rueth - Memorial Cancer Institute, Miami, USA

Future of chemotherapy and targeted therapies ( Dr Natasha Rueth - Memorial Cancer Institute, Miami, USA )

Transforming cancer care in India: The Access Cancer Care Initiative

Prof Richard Sullivan, Dr Ishu Kataria and Dr Arunah Chandran

Transforming cancer care in India: The Access Cancer Care Initiative ( Prof Richard Sullivan, Dr Ishu Kataria and Dr Arunah Chandran )

More from ecancer